{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:08:30Z","timestamp":1785413310224,"version":"3.56.0"},"reference-count":43,"publisher":"Siapec Servizi Srl","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologica"],"DOI":"10.32074\/1591-951x-1104","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T12:34:24Z","timestamp":1751978064000},"page":"296-305","source":"Crossref","is-referenced-by-count":3,"title":["KDM6A expression loss is frequent in low grade non-invasive urothelial carcinomas of the urinary bladder"],"prefix":"10.32074","volume":"117","author":[{"given":"Florian","family":"Viehweger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Gorbokon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyma","family":"B\u00fcy\u00fccek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Plage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Hofbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kira","family":"Furlano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Ralla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Fendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Biernath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Erber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Ro\u00dfner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Schallenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sefer","family":"Elezkurtaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Lennartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Hube-Magg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas H","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Samtleben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margit","family":"Fisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Slojewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystian","family":"Kaczmarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Ecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Adamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Weischenfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Klatte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Schlomm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Kluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Minner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21774","published-online":{"date-parts":[[2025,6]]},"reference":[{"key":"10.32074\/1591-951X-1104_ref1","doi-asserted-by":"crossref","unstructured":"Comploj E, Trenti E, Palermo S, et al. Urinary cytology in bladder cancer: why is it still relevant? Urologia. 2015;82:203-205. https:\/\/doi.org\/10.5301\/uro.5000129","DOI":"10.5301\/uro.5000129"},{"key":"10.32074\/1591-951X-1104_ref2","doi-asserted-by":"crossref","unstructured":"Wang G, Black PC, Goebell PJ, et al. Prognostic markers in pT3 bladder cancer: A study from the international bladder cancer tissue microarray project. Urol Oncol. 2021;39:e317-e328. https:\/\/doi.org\/10.1016\/j.urolonc.2021.01.021","DOI":"10.1016\/j.urolonc.2021.01.021"},{"key":"10.32074\/1591-951X-1104_ref3","doi-asserted-by":"crossref","unstructured":"Comperat E, Amin MB, Cathomas R, et al. Current best practice for bladder cancer: a narrative review of diagnostics and treatments. Lancet. 2022;400:1712-1721. https:\/\/doi.org\/10.1016\/S0140-6736(22)01188-6","DOI":"10.1016\/S0140-6736(22)01188-6"},{"key":"10.32074\/1591-951X-1104_ref4","doi-asserted-by":"crossref","unstructured":"Hurst CD, Alder O, Platt FM, et al. Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency. Cancer Cell. 2017;32:701-715.e707. https:\/\/doi.org\/10.1016\/j.ccell.2017.08.005","DOI":"10.1016\/j.ccell.2017.08.005"},{"key":"10.32074\/1591-951X-1104_ref5","doi-asserted-by":"crossref","unstructured":"Clinton TN, Chen Z, Wise H, et al. Genomic heterogeneity as a barrier to precision oncology in urothelial cancer. Cell Rep. 2022;41:111859. https:\/\/doi.org\/10.1016\/j.celrep.2022.111859","DOI":"10.1016\/j.celrep.2022.111859"},{"key":"10.32074\/1591-951X-1104_ref6","doi-asserted-by":"crossref","unstructured":"Hua C, Chen J, Li S, et al. KDM6 Demethylases and Their Roles in Human Cancers. Front Oncol. 2021;11:779918. https:\/\/doi.org\/10.3389\/fonc.2021.779918","DOI":"10.3389\/fonc.2021.779918"},{"key":"10.32074\/1591-951X-1104_ref7","doi-asserted-by":"crossref","unstructured":"Ler LD, Ghosh S, Chai X, et al. Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2. Sci Transl Med. 2017;9:eaa8312. https:\/\/doi.org\/10.1126\/scitranslmed.aai8312","DOI":"10.1126\/scitranslmed.aai8312"},{"key":"10.32074\/1591-951X-1104_ref8","doi-asserted-by":"crossref","unstructured":"Minner S, Kilgue A, Stahl P, et al. Y chromosome loss is a frequent early event in urothelial bladder cancer. Pathology. 2010;42:356-359. https:\/\/doi.org\/10.3109\/00313021003767298","DOI":"10.3109\/00313021003767298"},{"key":"10.32074\/1591-951X-1104_ref9","doi-asserted-by":"crossref","unstructured":"Damrauer JS, Beckabir W, Klomp J, et al. Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer. Nat Commun. 2022;13:6658. https:\/\/doi.org\/10.1038\/s41467-022-33980-9","DOI":"10.1038\/s41467-022-33980-9"},{"key":"10.32074\/1591-951X-1104_ref10","doi-asserted-by":"crossref","unstructured":"Nguyen B, Fong C, Luthra A, et al. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients. Cell. 2022;185:563-575.e511. https:\/\/doi.org\/10.1016\/j.cell.2022.01.003","DOI":"10.1016\/j.cell.2022.01.003"},{"key":"10.32074\/1591-951X-1104_ref11","doi-asserted-by":"crossref","unstructured":"Pietzak EJ, Zabor EC, Bagrodia A, et al. Genomic Differences Between \u201cPrimary\u201d and \u201cSecondary\u201d Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy. Eur Urol. 2019;75:231-239. https:\/\/doi.org\/10.1016\/j.eururo.2018.09.002","DOI":"10.1016\/j.eururo.2018.12.019"},{"key":"10.32074\/1591-951X-1104_ref12","doi-asserted-by":"crossref","unstructured":"Kim P H, Cha E K, Sfakianos J P, et al. Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder. Eur Urol. 2015;67:198-201. https:\/\/doi.org\/10.1016\/j.eururo.2014.06.050","DOI":"10.1016\/j.eururo.2014.06.050"},{"key":"10.32074\/1591-951X-1104_ref13","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research, N. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014;507:315-322. https:\/\/doi.org\/10.1038\/nature12965","DOI":"10.1038\/nature12965"},{"key":"10.32074\/1591-951X-1104_ref14","doi-asserted-by":"crossref","unstructured":"Barrows D, Feng L, Carroll T S, et al. Loss of UTX\/KDM6A and the activation of FGFR3 converge to regulate differentiation gene-expression programs in bladder cancer. Proc Natl Acad Sci U S A. 2020;117:25732-25741. https:\/\/doi.org\/10.1073\/pnas.2008017117","DOI":"10.1073\/pnas.2008017117"},{"key":"10.32074\/1591-951X-1104_ref15","doi-asserted-by":"crossref","unstructured":"Xiao J F, Kua L F, Ding L W, et al. KDM6A Depletion in Breast Epithelial Cells Leads to Reduced Sensitivity to Anticancer Agents and Increased TGFbeta Activity. Mol Cancer Res. 2022;20:637-649. https:\/\/doi.org\/10.1158\/1541-7786.MCR-21-0402","DOI":"10.1158\/1541-7786.MCR-21-0402"},{"key":"10.32074\/1591-951X-1104_ref16","doi-asserted-by":"crossref","unstructured":"Liu L, Cui J, Zhao Y, et al. KDM6A-ARHGDIB axis blocks metastasis of bladder cancer by inhibiting Rac1. Mol Cancer. 2021;20:77. https:\/\/doi.org\/10.1186\/s12943-021-01369-9","DOI":"10.1186\/s12943-021-01369-9"},{"key":"10.32074\/1591-951X-1104_ref17","doi-asserted-by":"crossref","unstructured":"Kaneko S, Li X. X chromosome protects against bladder cancer in females via a KDM6A-dependent epigenetic mechanism. Sci Adv. 2018;4:eaar5598. https:\/\/doi.org\/10.1126\/sciadv.aar5598","DOI":"10.1126\/sciadv.aar5598"},{"key":"10.32074\/1591-951X-1104_ref18","doi-asserted-by":"crossref","unstructured":"Andricovich J, Perkail S, Kai Y, et al. Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors. Cancer Cell. 2018;33:512-526.e518. https:\/\/doi.org\/10.1016\/j.ccell.2018.02.003","DOI":"10.1016\/j.ccell.2018.02.003"},{"key":"10.32074\/1591-951X-1104_ref19","doi-asserted-by":"crossref","unstructured":"Gorbokon N, Wossner N, Lennartz M, et al. Prevalence of S-methyl-5\u2019-thioadenosine Phosphorylase (MTAP) Deficiency in Human Cancer: A Tissue Microarray Study on 13,067 Tumors From 149 Different Tumor Types. Am J Surg Pathol. 2024. https:\/\/doi.org\/10.1097\/PAS.0000000000002297","DOI":"10.1097\/PAS.0000000000002297"},{"key":"10.32074\/1591-951X-1104_ref20","doi-asserted-by":"crossref","unstructured":"Hong S, Cho Y W, Yu L R, et al. Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases. Proc Natl Acad Sci U S A. 2007;104:18439-18444. https:\/\/doi.org\/10.1073\/pnas.0707292104","DOI":"10.1073\/pnas.0707292104"},{"key":"10.32074\/1591-951X-1104_ref21","doi-asserted-by":"crossref","unstructured":"Ahn J, Kim K H, Park S, et al. Target sequencing and CRISPR\/Cas editing reveal simultaneous loss of UTX and UTY in urothelial bladder cancer. Oncotarget. 2016;7:63252-63260. https:\/\/doi.org\/10.18632\/oncotarget.11207","DOI":"10.18632\/oncotarget.11207"},{"key":"10.32074\/1591-951X-1104_ref22","doi-asserted-by":"crossref","unstructured":"Greenfield A, Carrel L, Pennisi D, et al. The UTX gene escapes X inactivation in mice and humans. Hum Mol Genet. 1998;7:737-742. https:\/\/doi.org\/10.1093\/hmg\/7.4.737","DOI":"10.1093\/hmg\/7.4.737"},{"key":"10.32074\/1591-951X-1104_ref23","doi-asserted-by":"crossref","unstructured":"Rinn J L & Chang H Y. Genome regulation by long noncoding RNAs. Annu Rev Biochem. 2012;81:145-166. https:\/\/doi.org\/10.1146\/annurev-biochem-051410-092902","DOI":"10.1146\/annurev-biochem-051410-092902"},{"key":"10.32074\/1591-951X-1104_ref24","doi-asserted-by":"crossref","unstructured":"Schwartz Y B & Pirrotta V. Polycomb complexes and epigenetic states. Curr Opin Cell Biol. 2008;20:266-273. https:\/\/doi.org\/10.1016\/j.ceb.2008.03.002","DOI":"10.1016\/j.ceb.2008.03.002"},{"key":"10.32074\/1591-951X-1104_ref25","doi-asserted-by":"crossref","unstructured":"Hannon G J. RNA interference. Nature. 2002;418:244-251. https:\/\/doi.org\/10.1038\/418244a","DOI":"10.1038\/418244a"},{"key":"10.32074\/1591-951X-1104_ref26","doi-asserted-by":"crossref","unstructured":"Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401-404. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0095","DOI":"10.1158\/2159-8290.CD-12-0095"},{"key":"10.32074\/1591-951X-1104_ref27","doi-asserted-by":"crossref","unstructured":"Gao J, Aksoy B A, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1. https:\/\/doi.org\/10.1126\/scisignal.2004088","DOI":"10.1126\/scisignal.2004088"},{"key":"10.32074\/1591-951X-1104_ref28","doi-asserted-by":"crossref","unstructured":"de Bruijn I, Kundra R, Mastrogiacomo B, et al. Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal. Cancer Research. 2023;83:3861-3867. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0816","DOI":"10.1158\/0008-5472.CAN-23-0816"},{"key":"10.32074\/1591-951X-1104_ref29","doi-asserted-by":"crossref","unstructured":"Van Allen EM, Mouw KW, Kim P, et al. Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma. Cancer Discovery. 2014;4:1140-1153. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-0623","DOI":"10.1158\/2159-8290.CD-14-0623"},{"key":"10.32074\/1591-951X-1104_ref30","doi-asserted-by":"crossref","unstructured":"Guo G, Sun X, Chen C, et al. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nature Genetics. 2013;45:1459-1463. https:\/\/doi.org\/10.1038\/ng.2798","DOI":"10.1038\/ng.2798"},{"key":"10.32074\/1591-951X-1104_ref31","doi-asserted-by":"crossref","unstructured":"Robertson AG, Kim J, Al-Ahmadie H, et al. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell. 2017;171:540-556.e525. https:\/\/doi.org\/10.1016\/j.cell.2017.09.007","DOI":"10.1016\/j.cell.2017.09.007"},{"key":"10.32074\/1591-951X-1104_ref32","doi-asserted-by":"crossref","unstructured":"Iyer G, Al-Ahmadie H, Schultz N, et al. Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer. Journal of Clinical Oncology. 2013;31:3133-3140. https:\/\/doi.org\/10.1200\/JCO.2012.46.5740","DOI":"10.1200\/JCO.2012.46.5740"},{"key":"10.32074\/1591-951X-1104_ref33","doi-asserted-by":"crossref","unstructured":"Al-Ahmadie H, Iyer G, Lee BH, et al. Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer. Nature Genetics. 2016;48:356-358. https:\/\/doi.org\/10.1038\/ng.3503","DOI":"10.1038\/ng.3503"},{"key":"10.32074\/1591-951X-1104_ref34","doi-asserted-by":"crossref","unstructured":"Lee SH, Hu W, Matulay JT, et al. Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer. Cell. 2018;173:515-528.e517. https:\/\/doi.org\/10.1016\/j.cell.2018.03.017","DOI":"10.1016\/j.cell.2018.03.017"},{"key":"10.32074\/1591-951X-1104_ref35","doi-asserted-by":"crossref","unstructured":"Robinson BD, Vlachostergios PJ, Bhinder B, et al. Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling. Nature Communications. 2019;10:2977. https:\/\/doi.org\/10.1038\/s41467-019-10873-y","DOI":"10.1038\/s41467-019-10873-y"},{"key":"10.32074\/1591-951X-1104_ref36","doi-asserted-by":"crossref","unstructured":"Guercio BJ, Sarfaty M, Teo MY, et al. Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience. Clinical Cancer Research. 2023;29:4586-4595. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-1283","DOI":"10.1158\/1078-0432.CCR-23-1283"},{"key":"10.32074\/1591-951X-1104_ref37","doi-asserted-by":"crossref","unstructured":"Yamagishi M, Uchimaru K. Targeting EZH2 in cancer therapy. Current Opinion in Oncology. 2017;29:375-381. https:\/\/doi.org\/10.1097\/CCO.0000000000000390","DOI":"10.1097\/CCO.0000000000000390"},{"key":"10.32074\/1591-951X-1104_ref38","doi-asserted-by":"crossref","unstructured":"Hemming S, Cakouros D, Isenmann S, et al. EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification. Stem Cells. 2014;32:802-815. https:\/\/doi.org\/10.1002\/stem.1573","DOI":"10.1002\/stem.1573"},{"key":"10.32074\/1591-951X-1104_ref39","doi-asserted-by":"crossref","unstructured":"Tran N, Broun A, Ge K. Lysine Demethylase KDM6A in Differentiation, Development, and Cancer. Molecular and Cellular Biology. 2020;40. https:\/\/doi.org\/10.1128\/MCB.00341-20","DOI":"10.1128\/MCB.00341-20"},{"key":"10.32074\/1591-951X-1104_ref40","doi-asserted-by":"crossref","unstructured":"Das P, Taube JH. Regulating Methylation at H3K27: A Trick or Treat for Cancer Cell Plasticity. Cancers (Basel). 2020;12. https:\/\/doi.org\/10.3390\/cancers12102792","DOI":"10.3390\/cancers12102792"},{"key":"10.32074\/1591-951X-1104_ref41","doi-asserted-by":"crossref","unstructured":"Ezponda T, Dup\u00e8re-Richer D, Will CM, et al. UTX\/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition. Cell Reports. 2017;21:628-640. https:\/\/doi.org\/10.1016\/j.celrep.2017.09.078","DOI":"10.1016\/j.celrep.2017.09.078"},{"key":"10.32074\/1591-951X-1104_ref42","doi-asserted-by":"crossref","unstructured":"Ramakrishnan S, Granger V, Rak M, et al. Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer. Cell Death & Differentiation. 2019;26:2100-2114. https:\/\/doi.org\/10.1038\/s41418-019-0278-9","DOI":"10.1038\/s41418-019-0278-9"},{"key":"10.32074\/1591-951X-1104_ref43","doi-asserted-by":"crossref","unstructured":"Hussain MHA, Kocherginsky M, Singh P, et al. A pilot study of tazemetostat and pembrolizumab in advanced urothelial carcinoma (ETCTN 10183). Journal of Clinical Oncology. 2023;41:506-506. https:\/\/doi.org\/10.1200\/JCO.2023.41.6_suppl.506","DOI":"10.1200\/JCO.2023.41.6_suppl.506"}],"container-title":["Pathologica"],"original-title":[],"link":[{"URL":"https:\/\/www.pathologica.it\/article\/view\/1104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T12:40:26Z","timestamp":1751978426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.pathologica.it\/article\/view\/1104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,6]]}},"URL":"https:\/\/doi.org\/10.32074\/1591-951x-1104","relation":{},"ISSN":["1591-951X"],"issn-type":[{"value":"1591-951X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"article-number":"11"}}